BioSpace News Archive

Business

IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance

IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance Second quarter revenue $2,521 million and Adjusted EBITDA $483 million GAAP Diluted Earnings per Share $(0.12); Adjusted Diluted Earnings per Share $1.18 R&D Solutions quarterly net book-to-bill ratio 1.64x including pass throughs and 1.60x excluding pass throughs; contracted backlog including pass throughs grew 13.5 percent year-over-year to $20.5 billion

July 22, 2020
·
23 min read
Biotech Bay

Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams

Life sciences companies and doctors can leverage Veeva CRM Engage Meeting across the online meeting platforms they’re already using

July 22, 2020
·
3 min read
Biotech Bay

Syneos Health Strengthens Commercial Services with Veeva Commercial Cloud

Veeva Systems (NYSE: VEEV) today announced that Syneos Health (NASDAQ: SYNH), one of the industry’s largest providers of outsourced field teams, is offering biopharmaceutical customers Veeva Commercial Cloud solutions.

July 22, 2020
·
4 min read
Business

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

Vesigen Therapeutics launched today launched today with the objective to overcome the hurdle of targeted intracellular drug delivery of next-generation therapeutics, such as CRISPR-cas9,

July 22, 2020
·
7 min read
Business

Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.

July 22, 2020
·
11 min read
Deals

CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock

CytoSorbents Corporation (Nasdaq: CTSO) (the “Company”), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, today announced the pricing of its previously announced un

July 22, 2020
·
6 min read
Biotech Bay

Trianni Secures an EU Patent on the Trianni Mouse® Antibody Discovery Platform

Trianni, Inc. (“TRIANNI”) announced today that the European Patent Office granted patent EP 2597945 for TRIANNI’s leading technology, The Trianni Mouse®. The Trianni Mouse is a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies.

July 22, 2020
·
1 min read
Hydrocephalus Shunts Market - The new innovations are shown to dispose of the requirement for medical procedure

Shunting is the most well-known treatment for anybody with hydrocephalus (overabundance liquid development in the ventricles of the cerebrum).

July 22, 2020
·
3 min read
Intraoperative Imaging Market - Manufacturers are focusing on developing intraoperative imaging devices and tools with advanced functionalities

The healthcare industry is readily aspiring new technology that can enable caregivers to treat their patients better and the advent of intraoperative imaging has been in sync with it.

July 22, 2020
·
6 min read
Pharm Country

Potable Water in Buildings Unoccupied During COVID-19 Pandemic Contains Far More Bacteria than in Occupied Buildings; Legionella does not Predominate

Nephros SequaPath™, a new microbial screening system, used to evaluate 88 building water samples across four US geographic regions

July 22, 2020
·
6 min read